Company Filing History:
Years Active: 2009-2012
Title: Ute Schöber: Innovator in Cellular Research
Introduction
Ute Schöber, located in Berlin, Germany, is a distinguished inventor known for her significant contributions to cellular research, particularly in the field of oncology. With three patents to her name, her work focuses on the development of innovative tumour cell lines and their applications in cancer treatment and prevention.
Latest Patents
One of Ute's latest patents revolves around the development of specific tumour cell lines, designated as NM-F9 and NM-D4, with DSMZ accession numbers DSM ACC2606 and DSM ACC2605, respectively. The invention details a lysate of these cell lines and molecules derived from them, along with dendritic cells loaded with the lysate. Additionally, her patent provides pharmaceutical and vaccine compositions that encompass these cell lines and corresponding components. These innovations serve as a foundation for methods aimed at producing compositions for vaccination against, or treatment and prevention of, various cancers and tumourous diseases.
Career Highlights
Ute Schöber has had a commendable career, having made a mark in the biotechnology sector. She has worked with reputable companies, such as Glycotope GmbH and Glycotype GmbH, where she applied her expertise in cellular research to drive forward innovative solutions in cancer therapy.
Collaborations
During her career, Ute has collaborated with notable colleagues, including Steffen Goletz and Hans Baumeister. These partnerships have further enriched her research and fostered advancements in her field.
Conclusion
Ute Schöber stands out as a key innovator in cellular research, whose patents and collaborative efforts are poised to make a difference in the landscape of cancer treatment. Her commitment to advancing medical science showcases the vital role that inventors play in shaping healthcare solutions for the future.